Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VEP with H5N1 Vaccine in Healthy Adults
NCT01353534Phase 2Completed
- Sponsor
- Intercell AG
- Start
- May 2011
- Primary completion
- Dec 2011
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery
- Countries
- 2
01
Overview
A Phase 2 trial of Vaccine Enhancement Patch in Influenza A H5N1 infection (H5N1), sponsored by Intercell AG. Started May 2011; status: completed.
02
Drugs
Vaccine Enhancement Patch
03
Conditions
Influenza A H5N1 infection (H5N1)
Beyond the preview
Go deeper on NCT01353534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01353534.